Skip to main content Help with accessibility Skip to main navigation

Shared-care Guidelines

***PLEASE NOTE: Guidance is being issued by SPS recommending extended monitoring intervals for medication issued under a shared-care agreement during the COVID-19 NHS response - MLCSU reviewed and locally adapted versions of this guidance can be accessed here: MLCSU Central COVID-19 resource page. Please check back regularly for updates***

**Please note — Morecambe Bay CCG have agreed to the Atypical Antipsychotic Shared Care Guidelines for use in patients that fall under LCFT; for patients in South Cumbria the Cumbria Shared Care Guidelines should be followed

**Please note — For Blackpool, Fylde & Wyre CCG DMARD Shared Care Guidelines please use the versions available on the CCG website 

DMARDs Shared Care Agreement (Version 1.1)

Not adopted
Not adopted
Adopted
Not adopted
Not adopted
Adopted
Adopted
Adopted
Date Posted: 01 - September - 2018

Licensed – Active, progressive rheumatoid arthritis, progressive juvenile chronic arthritis especially if polyarticular or seropositive.
Unlicensed – skin diseases including pemphigus

This guidance does not replace the SPC’s, which should be read in conjunction with this guidance.

Not adopted
Not adopted
Adopted
Not adopted
Not adopted
Adopted
Adopted
Adopted
Date Posted: 01 - September - 2018

Licensed: Rheumatoid arthritis; ulcerative colitis, Crohn’s disease in adults and children
Unlicensed: Sero-negative spondyloarthropathy including psoriatic arthritis and psoriasis.